Chun, J.W.; Lee, D.-e.; Han, N.; Heo, S.; Kim, H.; Lee, M.R.; Park, H.M.; Han, S.-S.; Park, S.-J.; Kim, T.H.;
et al. Mutant KRAS and GATA6 Stratify Survival in Patients Treated with Chemotherapy for Pancreatic Adenocarcinoma: A Prospective Cohort Study. Cancers 2025, 17, 896.
https://doi.org/10.3390/cancers17050896
AMA Style
Chun JW, Lee D-e, Han N, Heo S, Kim H, Lee MR, Park HM, Han S-S, Park S-J, Kim TH,
et al. Mutant KRAS and GATA6 Stratify Survival in Patients Treated with Chemotherapy for Pancreatic Adenocarcinoma: A Prospective Cohort Study. Cancers. 2025; 17(5):896.
https://doi.org/10.3390/cancers17050896
Chicago/Turabian Style
Chun, Jung Won, Dong-eun Lee, Nayoung Han, SooBeen Heo, Hyeji Kim, Mi Rim Lee, Hyeong Min Park, Sung-Sik Han, Sang-Jae Park, Tae Hyun Kim,
and et al. 2025. "Mutant KRAS and GATA6 Stratify Survival in Patients Treated with Chemotherapy for Pancreatic Adenocarcinoma: A Prospective Cohort Study" Cancers 17, no. 5: 896.
https://doi.org/10.3390/cancers17050896
APA Style
Chun, J. W., Lee, D.-e., Han, N., Heo, S., Kim, H., Lee, M. R., Park, H. M., Han, S.-S., Park, S.-J., Kim, T. H., Lee, W. J., Kim, Y.-H., Kong, S.-Y., & Woo, S. M.
(2025). Mutant KRAS and GATA6 Stratify Survival in Patients Treated with Chemotherapy for Pancreatic Adenocarcinoma: A Prospective Cohort Study. Cancers, 17(5), 896.
https://doi.org/10.3390/cancers17050896
